Cryopreserved Placental Membrane Allograft Reduces the Likelihood of Developing a New or Recurring Foot Ulcer and All-Cause Mortality in Diabetic Patients When Compared with Other Cellular- and Tissue-Based Products
Sign Up to like & getrecommendations! Published in 2022 at "Advances in Wound Care"
DOI: 10.1089/wound.2021.0123
Abstract: Objective: To compare outcomes for Medicare patients with diabetic foot ulcer(s) (DFU) receiving cryopreserved placental membrane containing viable cells (vCPM) to other Cellular- and Tissue-Based Products (CTPs). Approach: Patients with DFU and CTP use were… read more here.
Keywords: dfu; compared cellular; foot ulcer; mortality ... See more keywords